Common genetic variations in the LEP and LEPR genes, obesity and breast cancer incidence and survival.
Obesity is a strong risk factor for breast cancer in postmenopausal women and adverse prognostic indicator regardless of menopausal status. Leptin is an important regulator of adipose tissue mass and has been associated with tumor cell growth. Leptin exerts its effects through interaction with the leptin receptor (LEPR). We investigated whether genetic variations in the leptin (LEP) and LEPR genes are associated with risk of breast cancer, or once diagnosed, with survival. The polymorphisms LEP G-2548A and LEPR Q223R were characterized in population-based study consisting of mostly European-American women. The study examined 1,065 women diagnosed with first, primary invasive breast cancer between 1996 and 1997. Controls were 1,108 women frequency matched to the cases by 5-year age group. A modest increase in risk of developing breast cancer was associated with the LEP -2548AA genotype when compared to the LEP -2548GG genotype (age-adjusted OR = 1.30; 95% CI = 1.01-1.66). This association was stronger among postmenopausal women who were obese (OR = 1.86; 95% CI = 0.95-3.64) although the interaction was of borderline statistical significance (P = 0.07). We found no evidence of an association with polymorphisms of either LEP or LEPR in relation to all-cause or breast cancer-specific mortality among women with breast cancer (mean follow-up time = 66.7 months). The effects of these genotypes on breast cancer risk and mortality did not vary significantly when stratified by menopausal status. In summary, our results show that a common variant in LEP may be associated with the risk of developing breast cancer supporting the hypothesis that leptin is involved in breast carcinogenesis.
Cleveland
Rebecca J
RJ
Department of Nutrition, School of Public Health, University of North Carolina, Chapel Hill, NC 27599-7461, USA. becki@unc.edu
Gammon
Marilie D
MD
Long
Chang-Min
CM
Gaudet
Mia M
MM
Eng
Sybil M
SM
Teitelbaum
Susan L
SL
Neugut
Alfred I
AI
Santella
Regina M
RM
D001943:Breast Neoplasms / Q000453:epidemiology* / Q000235:genetics / Q000401:mortality; D016022:Case-Control Studies; D002423:Cause of Death; D005060:Europe / Q000208:ethnology; D005260:Female; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D015994:Incidence; D020738:Leptin / Q000235:genetics* / Q000502:physiology; D008593:Menopause; D009518:New York / Q000453:epidemiology; D009765:Obesity / Q000453:epidemiology* / Q000235:genetics; D020641:Polymorphism, Single Nucleotide; D016016:Proportional Hazards Models; D054411:Receptors, Leptin / Q000235:genetics*; D012307:Risk Factors; D016019:Survival Analysis
C515448:LEPR protein, human; D020738:Leptin; D054411:Receptors, Leptin
Med Sci Monit. 2002 Dec;8(12):RA282-92
12503048
Int J Cancer. 1999 Feb 9;80(4):523-6
9935151
J Clin Endocrinol Metab. 2001 Sep;86(9):4434-9
11549688
Am J Clin Nutr. 1999 Apr;69(4):584-96
10197558
Metabolism. 2004 Jul;53(7):879-85
15254881
J Clin Oncol. 2004 Sep 1;22(17):3558-62
15337805
Am J Epidemiol. 2005 Jul 15;162(2):101-14
15972940
Clin Cancer Res. 2004 Jul 1;10(13):4325-31
15240518
Cancer Lett. 2006 Jun 8;237(1):137-42
16011872
Prostate. 2004 May 15;59(3):268-74
15042602
Ann Hum Genet. 2000 Sep;64(Pt 5):391-4
11281277
World Health Organ Tech Rep Ser. 1995;854:1-452
8594834
Eur J Cancer. 2006 May;42(8):1188-93
16630717
Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1803-11
17855698
Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1686-91
16030102
Cell Res. 2000 Jun;10(2):81-92
10896170
J Steroid Biochem Mol Biol. 2006 Jun;99(4-5):189-96
16621515
Horm Metab Res. 2002 Jul;34(7):355-9
12189581
Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1576-8
15941977
Breast Cancer Res Treat. 2002 Jun;74(3):235-54
12206514
Clin Endocrinol (Oxf). 2003 Feb;58(2):213-9
12580938
Nat Med. 1995 Sep;1(9):953-6
7585224
Breast Cancer Res Treat. 2004 Aug;86(3):191-6
15567935
J Clin Oncol. 2002 Feb 15;20(4):1128-43
11844838
J Natl Cancer Inst. 2002 Nov 20;94(22):1704-11
12441326
Nutr Cancer. 2003;45(1):1-16
12791499
Genomics. 1991 Dec;11(4):1054-62
1686014
Nature. 1994 Dec 1;372(6505):425-32
7984236
J Clin Endocrinol Metab. 2000 Jan;85(1):29-34
10634359
J Clin Oncol. 2005 Sep 1;23(25):6037-42
16135472
Br J Cancer. 2005 Oct 3;93(7):811-6
16160698
Breast Cancer Res Treat. 2006 Jul;98(2):157-65
16502016
Int J Oncol. 2002 Dec;21(6):1285-92
12429979
Int J Cancer. 2006 Mar 15;118(6):1414-9
16206269
Diabetologia. 1978 Mar;14(3):141-8
350680
Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):380-3
12692114
Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):779-86
15159310
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
11234459
Am J Epidemiol. 2005 Aug 1;162(3):229-37
15987723
BMC Cancer. 2006 Feb 20;6:38
16504019
J Biol Chem. 2006 Sep 8;281(36):26320-8
16825198
Cancer Causes Control. 2000 May;11(5):383-8
10877331